These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 16168274)

  • 1. Atherothrombosis and high-risk plaque: part I: evolving concepts.
    Fuster V; Moreno PR; Fayad ZA; Corti R; Badimon JJ
    J Am Coll Cardiol; 2005 Sep; 46(6):937-54. PubMed ID: 16168274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of the vulnerable plaque.
    Virmani R; Burke AP; Farb A; Kolodgie FD
    J Am Coll Cardiol; 2006 Apr; 47(8 Suppl):C13-8. PubMed ID: 16631505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerotic plaque rupture and thrombosis. Evolving concepts.
    Fuster V; Stein B; Ambrose JA; Badimon L; Badimon JJ; Chesebro JH
    Circulation; 1990 Sep; 82(3 Suppl):II47-59. PubMed ID: 2203564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New aspects in the pathogenesis of diabetic atherothrombosis.
    Moreno PR; Fuster V
    J Am Coll Cardiol; 2004 Dec; 44(12):2293-300. PubMed ID: 15607389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concept of vulnerable/unstable plaque.
    Finn AV; Nakano M; Narula J; Kolodgie FD; Virmani R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1282-92. PubMed ID: 20554950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New insights into the etiopathogenesis of atherosclerosis and atherothrombosis].
    Herman AG
    Bull Mem Acad R Med Belg; 2006; 161(3-4):213-25; discussion 226-7. PubMed ID: 17172227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of plaque disruption and thrombosis in acute ischemic syndromes.
    Moreno PR
    J Stroke Cerebrovasc Dis; 2001; 10(2 Pt 2):2-9. PubMed ID: 17903843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes.
    Zhou J; Chew M; Ravn HB; Falk E
    Scand J Clin Lab Invest Suppl; 1999; 230():3-11. PubMed ID: 10389196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis, a major determinant of atherothrombosis.
    Tedgui A; Mallat Z
    Arch Mal Coeur Vaiss; 2003 Jun; 96(6):671-5. PubMed ID: 12868350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells: multipotent local effector cells in atherothrombosis.
    Kovanen PT
    Immunol Rev; 2007 Jun; 217():105-22. PubMed ID: 17498055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the vulnerable patient with rupture-prone plaque.
    Weintraub HS
    Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis formation on atherosclerotic lesions and plaque rupture.
    Badimon L; Vilahur G
    J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
    Naghavi M; Libby P; Falk E; Casscells SW; Litovsky S; Rumberger J; Badimon JJ; Stefanadis C; Moreno P; Pasterkamp G; Fayad Z; Stone PH; Waxman S; Raggi P; Madjid M; Zarrabi A; Burke A; Yuan C; Fitzgerald PJ; Siscovick DS; de Korte CL; Aikawa M; Juhani Airaksinen KE; Assmann G; Becker CR; Chesebro JH; Farb A; Galis ZS; Jackson C; Jang IK; Koenig W; Lodder RA; March K; Demirovic J; Navab M; Priori SG; Rekhter MD; Bahr R; Grundy SM; Mehran R; Colombo A; Boerwinkle E; Ballantyne C; Insull W; Schwartz RS; Vogel R; Serruys PW; Hansson GK; Faxon DP; Kaul S; Drexler H; Greenland P; Muller JE; Virmani R; Ridker PM; Zipes DP; Shah PK; Willerson JT
    Circulation; 2003 Oct; 108(14):1664-72. PubMed ID: 14530185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From vulnerable plaque to atherothrombosis.
    Thim T; Hagensen MK; Bentzon JF; Falk E
    J Intern Med; 2008 May; 263(5):506-16. PubMed ID: 18410594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary atherosclerosis and thrombosis.
    Verstraete M
    Recenti Prog Med; 1990 Apr; 81(4):221-7. PubMed ID: 2198640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability.
    Moreno PR; Purushothaman KR; Fuster V; Echeverri D; Truszczynska H; Sharma SK; Badimon JJ; O'Connor WN
    Circulation; 2004 Oct; 110(14):2032-8. PubMed ID: 15451780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis as a determinant of atherothrombosis.
    Tedgui A; Mallat Z
    Thromb Haemost; 2001 Jul; 86(1):420-6. PubMed ID: 11487033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor expression in the morphologic spectrum of vulnerable atherosclerotic plaques.
    van der Wal AC; Li X; de Boer OJ
    Semin Thromb Hemost; 2006 Feb; 32(1):40-7. PubMed ID: 16479461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.